The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Unilife, Apple, Sony, Oncolytics, Biodel, BlackBerry

Mon, 09th Sep 2013 12:46

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 9 (Reuters) - Some U.S. stocks to watch on Monday:

FUTURES RISE AFTER CHINA DATA; SYRIA CONCERNS REMAIN

U.S. stock index futures advanced in the wake of upbeateconomic data from China, though concerns remained about apotential strike against Syria. S&P 500 futures rose 3.3points and were above fair value, a formula that evaluatespricing by taking into account interest rates, dividends andtime to expiration on the contract. Dow Jones industrial averagefutures gained 32 points, and Nasdaq 100 futures added 14 points.

** APPLE INC, Friday close $498.22, up 1.2 pctpremarket

Brokerage FBN Securities raised its price target on thecompany's stock to $600 from $575 in anticipation of Applemaking an announcement of its iPhone 5S and iPhone 5C onTuesday. The brokerage said it expected the phones to startshipping on Sept. 20. FBN sees the iPhone 5C as an opportunityfor Apple to be successful in China.

** UNILIFE CORP, Friday close $3.07, up 25 pctpremarket

The medical device maker said it entered into a long-termcontract to supply pre-filled syringes to Sanofi SA for use with Sanofi's thrombosis drug, Lovenox.

In addition to future revenue from the sale of the syringes,Unilife may receive up to $15 million from Sanofi in milestonepayments, with $5 million expected in 2013. The contract periodcan extend up to 2024.

** ONCOLYTICS BIOTECH INC, Friday close $2.65, up17 pct premarket

The company said its cancer drug, Reolysin, reduced the sizeof tumors in 92 percent of lung cancer patients in a mid-stagetrial.

** BIODEL INC, Friday close $5.03, up 12 pctpremarket

The pharmaceutical company said on Sunday that preliminarydata showed its fast-acting regular human insulin BIOD-123 metits goal in a mid-stage trial.

** ISIS PHARMACEUTICALS INC, Friday close $27.92,up 7 pct premarket

Biogen Idec Inc has agreed to pay another $100million upfront to the drugmaker as a part of a broadcollaboration to develop new medicines for neurologicaldisorders, the companies said.

** DELTA AIRLINES, Friday close $19.89, up 5 pctpremarket

The U.S. airline will join the S&P 500 index after the closeof trading on Sept. 10, replacing BMC Software, Standard& Poor's said on Friday.

** BLACKBERRY LTD, Friday close $10.84, up 4.3 pctpremarket

The company's largest shareholder, Prem Watsa, has assembledbillions in backing from Canada's biggest pension funds for abid, The Sunday Times reported on Sunday. (http://link.reuters.com/caz82v)

Watsa is the founder and chairman of Fairfax FinancialHoldings Ltd that holds about 10 percent stake in the company.

** SMITHFIELD FOODS INC, Friday close $33.92, up 2pct after market

The U.S. Committee on Foreign Investment has cleared the wayfor Shuanghui International Holdings Ltd's proposed $4.7 billionacquisition of Smithfield Foods, the companiessaid.

** NETAPP INC, Friday close $42.24, up 2.8 pctpremarket

Brokerage UBS Investment Research raised its rating on thedata storage equipment maker's stock to "buy" from "neutral,"according to the website Theflyonthewall.com.

** JOHNSON & JOHNSON, Friday close $87.16, up 1 pctpremarket

The company has launched a sale process for its OrthoClinical Diagnostics unit, which makes blood screening equipmentand laboratory blood tests and could fetch around $5 billion.J&J has asked JPMorgan Chase & Co to run the sale and ispreparing to send detailed financial information in coming weeksto potential buyers.

** VODAFONE PLC, Friday close $32.89

The company may fail to reach the 75 percent threshold ofacceptances from shareholders needed to clinch Germany's largestcable operator Kabel Deutschland, the Financial Timessaid. Vodafone agreed a 7.7 billion euro ($10.13 billion) offerfor Kabel Deutschland in June, a near 40 percent premium toKabel's share price before its interest first emerged.

** SONY CORP, Friday close $21.02, down 2 pct aftermarket

The electronics maker announced the Japanese release of itsPlayStation 4 on Monday as the company braces for a gamingconsole war with Microsoft Corp that could make orbreak the Japanese firm's struggle to return to profit.

** GLAXOSMITHKLINE PLC, Friday close $51.67

Japan's Suntory Beverage & Food Ltd is to buyGlaxoSmithKline's Lucozade and Ribena brands for 1.35 billionpounds ($2.11 billion) to expand into new markets.

** GOOGLE INC, Friday close $879.58

The U.S. government tapped into computer networks ofcompanies including Google and Brazilian state-run oil firmPetroleo Brasileiro SA, according to leaked U.S.documents aired by Globo, Brazil's biggest television network.

** TIME WARNER INC, Friday close $61.45

The entertainment company is planning to transfer its U.S.retirees from company-sponsored health plans and move them toprivate insurance exchanges. According to an August memoobtained by Reuters, the media company will make allocations toa Health Reimbursement Arrangement account for retirees to usetowards the purchase of coverage on an exchange. Previously,Time Warner provided an indirect subsidy through a supplementaryMedicare program. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.